Intranasal insulin improves memory in humans

  title={Intranasal insulin improves memory in humans},
  author={Christian Benedict and Manfred Hallschmid and A. T. Hatke and Bernd Schultes and Horst Lorenz Fehm and Jan Born and Werner Kern},

Figures and Tables from this paper

Intranasal Insulin to Improve Memory Function in Humans

Intranasal administration of insulin improves hippocampus-dependent declarative memory, but in the absence of adverse peripheral side effects, considering that cerebrospinal fluid insulin levels are reduced in patients suffering from Alzheimer’s disease.

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart

Results indicate that insulin-induced memory improvement can be enhanced by using rapid-acting insulin analog insulin aspart (ASP-I), and may be especially relevant for a potential clinical administration of intranasal insulin in the treatment of memory disorders like Alzheimer's disease.

Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

The findings suggest that groups with different genetic risks for AD may show differential dose-response curves following intranasal insulin administration, and whether the effects of insulin differ between participants with and without the APOE- epsilon4 allele.

Intranasal insulin improves cognition and modulates β-amyloid in early AD

The results of this pilot study support further investigation of the benefits of intranasal insulin for patients with Alzheimer disease, and suggest that intran asal peptide administration may be a novel approach to the treatment of neurodegenerative disorders.

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging.

The results suggest that the Ca(2+)-dependent hippocampal afterhyperpolarization may be a novel cellular target of insulin in the brain, and improved cognitive performance following intranasal insulin therapy may be the result of insulin actions on the AHP.

Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men

Results indicate that catabolic long-term effects of central nervous insulin delivery necessitate repetitive, presumably pre-meal delivery schedules, and suggest that sleep after intranasal insulin administration may support its beneficial cognitive impact.

Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism

Evidence is reviewed that suggests a pathophysiological role of impaired brain insulin signaling in obesity and type 2 diabetes, which are hallmarked by peripheral and possibly central nervous insulin resistance, as well as in conditions such as Alzheimer's disease where CNS insulin resistance might contribute to cognitive dysfunction.

Intranasal insulin

The negative outcomes of longer‐term IN insulin trials in individuals with obesity or Alzheimer's disease highlight the need for conceptual as well as methodological advances to translate the promising results of proof‐of‐concept experiments and pilot clinical trials into the successful clinical application of IN insulin.



Improving Influence of Insulin on Cognitive Functions in Humans

Results indicate an improving effect of insulin on cognitive function, and may provide a frame for further investigations of neurobehavioral effects of insulin in patients with lowered or enhanced brain insulin, i.e., patients with Alzheimer’s disease or diabetes mellitus.

Central nervous system effects of intranasally administered insulin during euglycemia in men.

The results suggest that after intranasal administration, insulin directly enters the brain and exerts distinct influences on central nervous functions in humans.

Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose.

It is confirmed that elevated insulin without hyperglycemia enhances memory in adults with AD, and indicates that insulin is essential for hyperglycemic memory facilitation.

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

Adult rats with icv-injected STZ developed long-term and progressive deficits in learning, memory, and cognitive behavior, indicated by decreases in working and reference memory in the holeboard task and the passive avoidance paradigm, along with a permanent and ongoing cerebral energy deficit.

The cellular and physiological actions of insulin in the central nervous system

Brain corticosteroid receptor balance in health and disease.

The balance in actions mediated by the two corticosteroid receptor types in these neurons appears critical for neuronal excitability, stress responsiveness, and behavioral adaptation and Dysregulation of this MR/GR balance brings neurons in a vulnerable state with consequences for regulation of the stress response and enhanced vulnerability to disease in genetically predisposed individuals.

Adaptation of cognitive function to hypoglycemia in healthy men.

Data provide evidence that a single episode of mild antecedent hypoglycemia attenuates several aspects of cognitive dysfunction during subsequent hypoglyCEmia 18-24 h later.

Memory consolidation in human sleep depends on inhibition of glucocorticoid release.

It is shown in healthy humans that an inhibition of glucocorticoid release from the adrenals serves to support declarative memory consolidation during sleep, and blocking mineralocortioid receptors by canrenoate did not affect memory, suggesting inactivation of glucOCorticoids receptors to be the essential prerequisite for memory consolidationduring early sleep.